4.7 Article

Transcriptomal Insights of Heart Failure from Normality to Recovery

Journal

BIOMOLECULES
Volume 12, Issue 5, Pages -

Publisher

MDPI
DOI: 10.3390/biom12050731

Keywords

heart failure; RNA-Seq; hypertrophy; cardiac recovery; dilatation

Funding

  1. Saudi British HF Initiative [SBHFI2.3/008/009]
  2. King Faisal Specialist Hospital and Research Centre (Research Advisory Council (RAC)) [2000 002]
  3. British Aerospace Systems
  4. Saudi Arabian Economic Offset Secretariat

Ask authors/readers for more resources

Current management of heart failure focuses on symptom progression and left ventricular dysfunction. This study investigated transcriptome changes in a chronic progressive heart failure model and identified potential genes involved in the progression of heart failure for future targeted therapies.
Current management of heart failure (HF) is centred on modulating the progression of symptoms and severity of left ventricular dysfunction. However, specific understandings of genetic and molecular targets are needed for more precise treatments. To attain a clearer picture of this, we studied transcriptome changes in a chronic progressive HF model. Fifteen sheep (Ovis aries) underwent supracoronary aortic banding using an inflatable cuff. Controlled and progressive induction of pressure overload in the LV was monitored by echocardiography. Endomyocardial biopsies were collected throughout the development of LV failure (LVF) and during the stage of recovery. RNA-seq data were analysed using the PANTHER database, Metascape, and DisGeNET to annotate the gene expression for functional ontologies. Echocardiography revealed distinct clinical differences between the progressive stages of hypertrophy, dilatation, and failure. A unique set of transcript expressions in each stage was identified, despite an overlap of gene expression. The removal of pressure overload allowed the LV to recover functionally. Compared to the control stage, there were a total of 256 genes significantly changed in their expression in failure, 210 genes in hypertrophy, and 73 genes in dilatation. Gene expression in the recovery stage was comparable with the control stage with a well-noted improvement in LV function. RNA-seq revealed the expression of genes in each stage that are not reported in cardiovascular pathology. We identified genes that may be potentially involved in the aetiology of progressive stages of HF, and that may provide future targets for its management.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available